We use cookies on this site in order to make it works, and for the traffic analysis.
You can refuse or configure cookies by purposes.
Another message from the Google Adsense consent management platform will ask you for your choices relating to the use of your personal data via cookies for advertising.
We thank you to accept cookies which makes this site work.

ESCMID survey on the routine diagnosis and treatment of visceral leishmaniasis

Question 1

You work in :

uncheck

Comments

Question 2

Please specify your location : City and Country :

Question 3

There is a reference center for leishmaniasis in your country :

uncheck

Comments

Question 4

Your volume of analysis, please specify on an annual basis
- Number of suspected diagnosis of VL. Please specify :
- Number of positive diagnosis of VL. Please specify :

Question 5

Among these sample types, which one are possibly processed in your lab :

Comments

Question 6

Among these samples types, which one are possibly processed in your lab for direct examination and/or culture :

Comments

Question 7

Among these sample types, which one is recommended in first-line for the diagnosis of VL in your hospital :

Comments

Question 8

Direct examination is :

Comments

Question 9

Diagnosis Tools :
Direct examination is performed :

Comments

Question 10

Culture of Leishmania is :

Comments

Question 11

Culture is performed using (*supplemented with fetal calf serum +/- antibiotics) :

Comments

Question 12

Serological tests are :

Comments

Question 13

Serology is performed using :

Comments

Question 14

Molecular detection is :

Comments

Question 15

Molecular detection is performed using :

Comments

Question 16

Targets of the primers for PCR available in your lab are :

Comments

Question 17

Identification of Leishmania is performed using :

Comments

Question 18

Targets for the sequencing available in your lab are :

Comments

Question 19

Drugs available in your hospital for the treatment of VL are :

Comments

Question 20

The first-line treatment in adults is :

Comments

Question 21

The second-line treatment in adults is :

Comments

Question 22

The first-line treatment in children is :

Comments

Question 23

The second-line treatment in children is :

Comments

Question 24

When using liposomal Amphotericin B (Ambisome), please specify the total dose and administration schedule for :

Comments

Question 25

Do you perform in vitro sensitivity testing of Leishmania isolates in your lab :

uncheck

Comments

Question 26

Do you think that in vitro sensitivity testing of Leishmania would be helpful for the choice of the drug :

uncheck

Comments

Question 27

Do you use pharmacological drug monitoring in your hospital :

uncheck

Comments

Question 28

Do you think that pharmacological drug monitoring would be helpful for the choice of the drug :

uncheck

Comments

Question 29

At what term do you consider that the VL treatment succeeded of failed and on what sample :

Comments

Question 30

The first-line treatment for secondary prophylaxis in adults is :

Comments

Question 31

The first-line treatment for secondary prophylaxis in children is :

Comments

Question 32

When using liposomal Amphotericin B (Ambisome) for secondary prophylaxis, please specify the dose and administration schedule :

Question 33

When using another drug for secondary prophylaxis, please specify the dose and administration schedule :




You too, create your online questionnaire!
It's free and easy.
Let's go!